Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Agan

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
AIDS (London, England)|June 23, 2026
Genome-wide association study of cardiovascular disease in people with HIV from the Million Veteran Program (MVP)Boghuma K Titanji, Amonae Dabbs-Brown, Jennie T Mather, et al.
Plos One|July 23, 2025
The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemicsSimon D Pollett, Rhonda E Colombo, Stephanie A Richard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe LymphopeniaIrini Sereti, Virginia Sheikh, Douglas Shaffer, et al.
Research Square|December 3, 2020
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactionsEric Laing, Spencer Sterling, Stephanie Richard, et al.
Npj Viruses|April 28, 2025
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assayDanielle W Ali, Maggie L Bartlett, Christopher D Heger, et al.
Journal of Virology|October 4, 2024
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster seraWei Wang, Gitanjali L Bhushan, Stephanie Paz, et al.
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2024
Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodesMichael J Topper, Joseph W Guarnieri, Jeffrey A Haltom, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
AIDS (London, England)|June 23, 2026
Genome-wide association study of cardiovascular disease in people with HIV from the Million Veteran Program (MVP)Boghuma K Titanji, Amonae Dabbs-Brown, Jennie T Mather, et al.
Plos One|July 23, 2025
The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemicsSimon D Pollett, Rhonda E Colombo, Stephanie A Richard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe LymphopeniaIrini Sereti, Virginia Sheikh, Douglas Shaffer, et al.
Research Square|December 3, 2020
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactionsEric Laing, Spencer Sterling, Stephanie Richard, et al.
Npj Viruses|April 28, 2025
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assayDanielle W Ali, Maggie L Bartlett, Christopher D Heger, et al.
Journal of Virology|October 4, 2024
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster seraWei Wang, Gitanjali L Bhushan, Stephanie Paz, et al.
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2024
Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodesMichael J Topper, Joseph W Guarnieri, Jeffrey A Haltom, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 3